HAEMOPHILIA A WITH INHIBITORS
Clinical trials for HAEMOPHILIA A WITH INHIBITORS explained in plain language.
Never miss a new study
Get alerted when new HAEMOPHILIA A WITH INHIBITORS trials appear
Sign up with your email to follow new studies for HAEMOPHILIA A WITH INHIBITORS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New injection could drastically cut bleeds for hemophilia patients
Disease control CompletedThis study tested a new medicine called Mim8, given as a weekly or monthly injection, to prevent bleeding episodes in people with hemophilia A. It compared Mim8 to other standard treatments in 281 adults and adolescents, including those whose bodies make inhibitors against standa…
Matched conditions: HAEMOPHILIA A WITH INHIBITORS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
New hemophilia drug Mim8 tested for safe switch from current treatment
Disease control CompletedThis study checked if it was safe for people with hemophilia A to switch from their current preventive medicine, emicizumab, to a new one called Mim8. It involved 61 adults and adolescents who had been on emicizumab. Participants received Mim8 via a pen injector weekly, every two…
Matched conditions: HAEMOPHILIA A WITH INHIBITORS
Phase: PHASE3 • Sponsor: Novo Nordisk A/S • Aim: Disease control
Last updated Mar 27, 2026 12:39 UTC